Product specifications CAS Registry Number 170851-70-4 Reported purity 98.5% Form Lyophilized laboratory research material Intended use Qualified in vitro laboratory research only
Short-term protocols (1216 weeks) at standard doses carry minimal toxicity risk, but long-term use beyond 6 months lacks human safety data as of 2026
Common protocols use ipamorelin 1-3 times daily, typically before bed (to amplify the natural nocturnal GH pulse), upon waking (fasted), and/or post-exercise
However, they have recently gained traction in the mainstream conversation, drawing attention from athletes, biohackers, wellness experts, and everyday people seeking a more intelligent, more scientific edge
Eur Arch Otorrinolaringol
Knowing when to take your shotand sticking to that scheduledirectly impacts how effectively the medication controls hunger and supports your goals